Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant



Status:Recruiting
Conditions:Cervical Cancer, Ocular
Therapuetic Areas:Oncology, Ophthalmology
Healthy:No
Age Range:6 - Any
Updated:4/26/2017
Start Date:February 4, 2016
End Date:May 5, 2018
Contact:Anya Loncaric
Email:aloncaric@solta.com
Phone:510-782-2286

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

An Observational Bilateral Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant for at Least One Year

Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants

Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants on corneal
endothelial cell density.

Inclusion Criteria:

- Had the FA intravitreal implant (0.59 or 2.1 mg) in only one eye for at least one(1)
year

- Able and willing to follow instructions

- Able and willing to provide informed consent

Exclusion criteria:

- Is monocular

- Has current or relevant medical history that would interfere with their participation
in this study, based on the judgment of the Investigator

- Had bilateral FA intravitreal implants

- Has a history of any severe/serious ocular pathology or medical condition that could
result in the subject's inability to complete the study
We found this trial at
1
site
Ophthalmic Partners of Boston
Boston, Massachusetts 02114
?
mi
from
Boston, MA
Click here to add this to my saved trials